LISA GREENAN: Open Payments
NPI 1053567032 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 70 payments from 15 companies in 2025. Trend: 2023 $1,511 · 2024 $1,568 · 2025 $1,589
Food & beverage: $1,453Education: $136
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $284 |
| Novartis Pharmaceuticals Corporation | 9 | $256 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $196 |
| Regeneron Healthcare Solutions, Inc. | 8 | $194 |
| Galderma Laboratories, L.P. | 12 | $155 |
| LEO Pharma Inc. | 1 | $120 |
| Janssen Biotech, Inc. | 2 | $100 |
| GENZYME CORPORATION | 2 | $67 |
| ABBVIE INC. | 3 | $58 |
| Botanix SB Inc | 2 | $37 |
Products named: Bimzelx, DUPIXENT, COSENTYX, ANZUPGO, ILUMYA, TREMFYA, Rhapsido, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
